Establishment Labs Holdings Inc. - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Establishment Labs Holdings Inc. on August 20, 2024. The filing reports the appointment of a new executive officer effective immediately.
Key Financial Metrics
This filing does not contain financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity metrics. The document focuses exclusively on executive compensation and appointment details.
Material Changes
The primary material change reported is the appointment of Fillipo "Peter" Caldini as President of the Company, effective August 20, 2024. Mr. Caldini brings prior executive experience from Acreage Holdings, Bespoke Capital Acquisition Corp., Pfizer Consumer Healthcare, Bayer AG, and Wyeth Consumer Healthcare.
Compensation and Employment Terms
Mr. Caldini's employment agreement includes the following compensation structure:
- Base Salary: $415,000 annually.
- Annual Bonus: Target amount of 50% of base salary.
- Annual Equity Award: Grant date fair value equal to approximately 100% of base salary.
- New Hire Grant:
- Stock options with a fair value of $600,000.
- Restricted stock units (RSUs) with a fair value of $400,000.
- Vesting Schedule: One-quarter of the stock options and RSUs vest on each of the first four anniversaries of the start date.
Additional terms regarding severance and benefits are consistent with agreements for other executive officers as described in the Company's definitive proxy statement filed on April 12, 2024.
Investor Verification Checklist
- Verify the full text of the Employment Agreement attached as Exhibit 10.1 for specific severance and termination clauses.
- Review the definitive proxy statement filed on April 12, 2024, to understand the standard severance terms referenced in this filing.
- Confirm the closing price of the Company's common shares on August 20, 2024, to determine the exercise price for the granted stock options.
- Monitor future filings for any changes to the Company's long-term incentive equity grant program.